ArticleF1000 medicine reports2009
Updates in colorectal cancer screening.
Article in F1000 medicine reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in the field of colorectal cancer screening have led to updated guidelines from several national societies. Although various strategies have been illustrated to reduce mortality from colorectal cancer, screening tests differ in their ability to detect neoplasia. While this is an issue for all lesions, it is a particular problem for non-polypoid or 'flat' colonic neoplasia, which has been recognized to be prevalent in Western countries. Guidelines also recommend the age at which screening is initiated and discontinued; however, emerging data suggest these thresholds may lead to missed lesions. Finally, evidence points to disparities in the availability and utilization of colorectal cancer screening tests, which may be successfully addressed through interventions that educate both patients and their providers. The focus of future efforts includes increasing adherence to recommended screening strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.